Response to Hydrocortisone in an Extremely Preterm Neonate With Late-Onset Sepsis, Meningoencephalitis, and Drug-Resistant Seizures

Clin EEG Neurosci. 2024 Mar;55(2):252-256. doi: 10.1177/15500594221147138. Epub 2022 Dec 25.

Abstract

Corticosteroids are commonly used in children with bacterial meningitis; however, there are very few data regarding possible utility in neonates, particularly those born premature. We describe our experience using hydrocortisone in the treatment of a girl born at 26 weeks, 6 days gestation. She had suffered profound brain injury following late onset group B streptococcus sepsis and meningitis, and developed drug-resistant seizures. Because seizures continued despite treatment with phenobarbital, phenytoin, levetiracetam, lacosamide, and midazolam, intravenous hydrocortisone was added. We observed a marked decrease in focal electrographic seizures within 2 days of initiation of hydrocortisone. This experience suggests that corticosteroids could be a treatment option for drug-resistant seizures and status epilepticus in preterm neonates, particularly those with bacterial meningitis.

Keywords: encephalitis; hydrocortisone; meningitis; neonatal; seizure; steroids.

MeSH terms

  • Anticonvulsants / therapeutic use
  • Child
  • Electroencephalography / adverse effects
  • Female
  • Humans
  • Hydrocortisone
  • Infant, Extremely Premature
  • Infant, Newborn
  • Meningitis, Bacterial* / complications
  • Meningitis, Bacterial* / drug therapy
  • Meningoencephalitis* / complications
  • Meningoencephalitis* / drug therapy
  • Seizures / drug therapy
  • Sepsis* / complications
  • Sepsis* / drug therapy

Substances

  • Anticonvulsants
  • Hydrocortisone